R
René Adam
Researcher at Université Paris-Saclay
Publications - 634
Citations - 44864
René Adam is an academic researcher from Université Paris-Saclay. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 92, co-authored 578 publications receiving 37929 citations. Previous affiliations of René Adam include University of Padua & University of Paris.
Papers
More filters
Journal ArticleDOI
[32] moderate expansion of milan criteria for transplantation for hcc does not impact survival nor recurrence rates
H. Badran,C. Meyer,René Adam,Aurélie Plessier,François Durand,O. Boillot,Jérôme Dumortier,J. Dharancy,H.M. Hilleret,Thomas Decaens,Daniel Cherqui,Christophe Duvoux +11 more
Journal ArticleDOI
Beneficial effect of alanine on metabolic recovery of fasted livers submitted to cold ischemia.
Jacqueline Patry,René Adam,Yves Blouquit,Ibrahim Astarcioglu,Ashley R. Dennison,Jean-Luc Dimicoli,Henri Bismuth +6 more
TL;DR: The conclusion reached was that the lower pyruvate dehydrogenase activity of livers from fasted mice relatively to that from fed mice could be compensated for by the greater pyruVate concentration provided by alanine for the initial production of NTP after cold ischemia and warm reperfusion.
Journal ArticleDOI
High trough levels of everolimus combined to sorafenib improve patients survival after hepatocellular carcinoma recurrence in liver transplant recipients.
Hidetoshi Nitta,Aline Younès,Nada El-Domiaty,Nada El-Domiaty,V. Karam,Rodolphe Sobesky,Eric Vibert,Audrey Coilly,Teresa Antonini,Eleonora De Martin,Daniel Cherqui,Hideo Baba,Olivier Rosmorduc,René Adam,Didier Samuel,Faouzi Saliba +15 more
TL;DR: In this paper, the authors performed a study on 306 patients who underwent liver transplantation for hepatocellular carcinoma (HCC) and found that the combination of sorafenib and everolimus was an independent predictor for better survival after HCC recurrence.
Journal ArticleDOI
Serial volumetric assessment of large for size liver grafts after whole cadaveric liver transplant in adults: do large liver grafts shrink in size?
Mohamed Bekheit,Muthukumarassamy Rajakannu,Petru Bucur,René Adam,Antonio Sa-Cunha,Denis Castaing,Denis Castaing,Daniel Cherqui,Daniel Cherqui,Eric Vibert,Eric Vibert +10 more
TL;DR: There was a tendency, but none significant; towards a higher bilirubin, AST, ALT levels over the first postoperative days in recipients with GRWR > 3, and grafts weighing >3% of the GRWR show a different trend towards decrease in size over time.
Journal ArticleDOI
Cross-Talk Between Sirtuin 1 and High-Mobility Box 1 in Steatotic Liver Graft Preservation
Mohamed Amine Zaouali,Arnau Panisello,Alexandre Lopez,Emma Folch,Carlos Castro-Benitez,René Adam,Joan Roselló-Catafau +6 more
TL;DR: Elevated SIRT1 and enhanced autophagy were found after reperfusion in steatotic livers preserved in I GL-1+TMZ when compared with IGL-1, consistent with decreased liver injury diminution, ameliorated hepatic function, and decreased TNF-α and HMGB levels.